Buy, Sell or Hold: Six Reasons Pfizer Inc. (NYSE: PFE) is a Generational Buy

My parents are in their late 80s and still living life to the fullest. I honestly hope I live as long and am as active as they are today....

M&A Frenzy Stays Hot With Pfizer's $3.6 Billion Deal for King Pharmaceuticals

The frenzy of activity in mergers and acquisitions (M&A) continued yesterday (Tuesday), when Pfizer Inc. (NYSE:

Buy, Sell or Hold: Altria Group Inc. (NYSE: MO) - The 'Sin Stock' You Have to Own

With more than 1 billion smokers worldwide, it is hard to conceive that companies selling cigarettes would not be extremely profitable.  In...

Buy, Sell or Hold: Is Pfizer Inc. (NYSE: PFE) the Right Prescription for Your Portfolio?

In 2008, the journal Health Affairs reported that 25% of China's adult population  - about 375 million people - was...

Teva Pharmaceutical Wins Fight in the Generic Drug Market Battle

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will buy sought-after German generic producer Ratiopharm for $4.97 billion, continuing a trend of...

Which Stocks and Sectors Will Shine as Market Fear Subsides?

A lot of my commentary lately on the markets has been relatively short-term oriented. Today let's take a moment to pan back and consider the weekly...

Investment News Briefs

With our investment news briefs, Money Morning provides investors with a quick overview of the most important investing news stories from all around...

Pages 1 of 1